Literature DB >> 30104451

CL sensitisation of tris-(bipyridyl) ruthenium (II) - cerium (IV) reaction system by AgNPs for determination of GFX.

Saikh Mohammad Wabaidur1, Seikh M Alam2.   

Abstract

The flow injection combined with tris-(bipyridyl) ruthenium (II)-cerium (IV) chemiluminescence (CL) method based on the sensitisation of silver nanoparticles (AgNPs) has been established for the quantitative analysis of gatifloxacin (GFX). AgNPs were synthesised using the reaction between ammonia gas and silver nitrate solution and was used to increase the CL intensity of the proposed system. The enhancement of CL intensity was linear with the concentration of GFX added. Effects of different experimental parameters were studied. Under the optimal conditions, the linear relationship was established between the concentration range of 1.4 × 10-10-4.5 × 10-8 M, with the correlation coefficient (r2) 02E9999. The limit of detection was found to be 4.6 × 10-11 M. The relative standard deviation obtained was 3.2% for six replicate measurements of GFX (1.2 × 10-9 M). The proposed CL method was applied to the commercial drug and the result was in agreement with the labelled amount. The technique was further adopted to the analysis of GFX in spiked urine samples. Negligible interference was found (variation in CL intensity <5%) from a few common foreign excipients applied in preparation of pharmaceutical drug. The comparative results with a few reported methods indicates that the proposed method is more sensitive than other methods..

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30104451      PMCID: PMC8676307          DOI: 10.1049/iet-nbt.2018.0018

Source DB:  PubMed          Journal:  IET Nanobiotechnol        ISSN: 1751-8741            Impact factor:   1.847


  15 in total

1.  Determination of levofloxacin in plasma, bronchoalveolar lavage and bone tissues by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method.

Authors:  S Djabarouti; E Boselli; B Allaouchiche; B Ba; A T Nguyen; J B Gordien; J M Bernadou; M C Saux; D Breilh
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-01-05       Impact factor: 3.205

2.  Determination of levofloxacin in human urine by adsorptive square-wave anodic stripping voltammetry on a glassy carbon electrode.

Authors:  A Radi; Z El-Sherif
Journal:  Talanta       Date:  2002-08-23       Impact factor: 6.057

3.  Silver nanoparticles enhanced flow injection chemiluminescence determination of gatifloxacin in pharmaceutical formulation and spiked urine sample.

Authors:  Saikh mohammad Wabaidur; Seikh Mafiz Alam; Zeid A Alothman; Kazi Mohsin
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2015-02-21       Impact factor: 4.098

4.  Determination of gatifloxacin and ornidazole in tablet dosage forms by high-performance thin-layer chromatography.

Authors:  Bhanubhai N Suhagia; Shailesh A Shah; Ishwarsinh S Rathod; Haresh M Patel; Dinesh R Shah; Bhavin P Marolia
Journal:  Anal Sci       Date:  2006-05       Impact factor: 2.081

Review 5.  Clinical pharmacology of gatifloxacin, a new fluoroquinolone.

Authors:  D M Grasela
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

6.  Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of levofloxacin in human plasma.

Authors:  Hye Young Ji; Dong Won Jeong; Young Hoon Kim; Hui-Hyun Kim; Dong-Ryul Sohn; Hye Suk Lee
Journal:  J Pharm Biomed Anal       Date:  2006-01-19       Impact factor: 3.935

7.  Ultrasensitive study of gatifloxacin based on its enhancing effect on the cerium (IV)-sodium hyposulfite chemiluminescence reaction in a micellar medium.

Authors:  Mohammad Kamruzzaman; Al-Mahmnur Alam; Taslima Ferdous; Sang Hak Lee; Young Ho Kim; Sung Hong Kim
Journal:  J Fluoresc       Date:  2011-01-19       Impact factor: 2.217

8.  Fluorescence probe enhanced spectrofluorimetric method for the determination of gatifloxacin in pharmaceutical formulations and biological fluids.

Authors:  Xiashi Zhu; Aiqin Gong; Suhai Yu
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2007-05-01       Impact factor: 4.098

9.  Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones.

Authors:  Louis D Saravolatz; James Leggett
Journal:  Clin Infect Dis       Date:  2003-10-02       Impact factor: 9.079

10.  Chemiluminescence determination of barbituric acid using Ru(phen)(3)(2+)-Ce(IV) system.

Authors:  Juan Xi; Xinping Ai; Zhike He
Journal:  Talanta       Date:  2003-04-10       Impact factor: 6.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.